500
Participants
Start Date
September 14, 2022
Primary Completion Date
December 31, 2032
Study Completion Date
December 31, 2032
Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire
"Patients presenting with symptomatic ischemic heart disease (including chronic stable angina or unstable angina) without evidence of myocardial infarction who require elective or urgent cardiac catheterization, and who meet all eligibility criteria will be enrolled.~Participants will undergo routine coronary angiography as well as comprehensive physiologic assessment with intracoronary acetylcholine provocation for diagnosis of vasospastic angina (VSA), coronary thermodilution to evaluate for coronary microvascular dysfunction (CMD), and intracoronary imaging with optical coherence tomography (OCT) or intravascular ultrasound (IVUS) to evaluate for the presence of atheroma, plaque burden, and myocardial bridging."
RECRUITING
NYU Langone Health, New York
RECRUITING
Columbia University Irving Medical Center, New York
RECRUITING
New York Presbyterian-Brooklyn Methodist Hospital, Brooklyn
RECRUITING
Thomas Jefferson University Hospital, Philadelphia
RECRUITING
Northeast Georgia Medical Center, Gainesville
RECRUITING
The Christ Hospital, Cincinnati
RECRUITING
UCLA Health, Los Angeles
RECRUITING
Stanford Hospital, Stanford
RECRUITING
Yale New Haven Hospital, New Haven
Collaborators (1)
Abbott
INDUSTRY
Yale University
OTHER